Weifeng Huang

发表

Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A2A receptor (A2A AR) antagonist.

G. L. Reddy, Wenhao Hu, R. Sarma, 2020, European journal of medicinal chemistry.

Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer

Junfeng Wang, Yinfeng Guo, W. Deng, 2022, Cell death & disease.

Exploring Marine-Derived Ascochlorins as Novel Human Dihydroorotate Dehydrogenase Inhibitors for Treatment of Triple-Negative Breast Cancer.

Xuefeng Zhou, Xiaowei Luo, Chenghai Gao, 2021, Journal of medicinal chemistry.

Discovery of Novel Benzo[4,5]imidazo[1,2-a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists.

Taoda Shi, Yinfeng Guo, Xiaolei Zhang, 2022, Journal of medicinal chemistry.

Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy

Yong Rao, Zhishu Huang, Shi-Liang Huang, 2022, Molecules.

Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer

Yonghong Liu, Junfeng Wang, Peiqing Liu, 2021, Cell Death & Disease.

3D Conformational Generative Models for Biological Structures Using Graph Information-Embedded Relative Coordinates

Mingyuan Xu, Hongming Chen, Weifeng Huang, 2022, Molecules.

Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway

Shusheng Wang, Hong Wang, Xiaowei Luo, 2021, Frontiers in Pharmacology.

DRlinker: Deep Reinforcement Learning for Optimization in Fragment Linking Design

Yuedong Yang, Yinfeng Guo, Weifeng Huang, 2022, J. Chem. Inf. Model..

Deep learning-based design and screening of benzimidazole-pyrazine derivatives as adenosine A2B receptor antagonists.

Weifeng Huang, Jinping Lei, Rui Qin, 2023, Journal of biomolecular structure & dynamics.

Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design.

Weifeng Huang, Sifan Yu, Jinping Lei, 2024, European journal of medicinal chemistry.

Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16

Liu Cao, Weifeng Huang, T. Xu, 2024, Molecules.